• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

首次发作精神分裂症患者的功能总体评估得分与功能、严重程度及预后指标之间的关联

Association between Global Assessment of Functioning scores and indicators of functioning, severity, and prognosis in first-time schizophrenia.

作者信息

Köhler Ole, Horsdal Henriette Thisted, Baandrup Lone, Mors Ole, Gasse Christiane

机构信息

Psychosis Research Unit, Aarhus University Hospital, Risskov.

National Centre for Register-based Research, Department of Economics and Business Economics, Aarhus University, Aarhus.

出版信息

Clin Epidemiol. 2016 Sep 2;8:323-32. doi: 10.2147/CLEP.S109036. eCollection 2016.

DOI:10.2147/CLEP.S109036
PMID:27660490
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5019159/
Abstract

BACKGROUND

Assessment of psychosocial functioning in people with schizophrenia is important. The Global Assessment of Functioning (GAF-F) scale represents a widely applied, easy, and quick tool, but its validity and reliability have been debated. The aim was to investigate whether GAF-F scores are associated with other indicators of functioning, severity, and hospitalization.

METHODS

A Danish population-based cohort study of adults (≥18 years) with a recorded GAF-F score at first-time schizophrenia diagnosis during 2004-2011 was performed. The internal validity of GAF-F was evaluated by assessing its association with other baseline measures of functioning and illness severity. Risk of schizophrenia hospitalization within 2 years was evaluated using Cox regression stratified by sex and adjusted for age, year of diagnosis, and inpatient/outpatient status at diagnosis.

RESULTS

We identified 2,837 cases of schizophrenia with a GAF-F score at first-time diagnosis (73.0% inpatients; 62.6% males). GAF-F was associated with several baseline measures of functioning and illness severity, such as female sex, being in work, and a longer baseline hospitalization. Lower GAF-F scores were associated with higher hospitalization risk among males (reference GAF-F 61-100): GAF-F 51-60: hazard rate ratio (HRR) =1.24 (95% confidence interval [CI] =0.89-1.75); GAF-F 41-50: HRR =1.31 (95% CI =0.97-1.77); GAF-F 31-40: HRR =1.36 (95% CI =1.01-1.82); GAF-F 21-30: HRR =1.50 (95% CI =1.09-2.06); and GAF-F 1-20: HRR =2.30 (95% CI =1.36-3.90), fitting a dose-response relationship (P=0.031). This association was not found in females.

CONCLUSION

GAF-F at first-time schizophrenia diagnosis showed good internal validity against other measures of functionality in a Danish hospital setting. Severe impairment (as measured by the GAF-F score) at first-time schizophrenia diagnosis was associated with a higher risk of 2-year hospitalization among males, which may indicate sex differences in the course of disease and treatment response.

摘要

背景

评估精神分裂症患者的心理社会功能很重要。全球功能评估(GAF-F)量表是一种广泛应用、简便快捷的工具,但其有效性和可靠性一直存在争议。目的是调查GAF-F评分是否与其他功能、严重程度及住院指标相关。

方法

对2004年至2011年首次诊断为精神分裂症且有记录GAF-F评分的丹麦成年(≥18岁)人群进行队列研究。通过评估GAF-F与其他功能和疾病严重程度基线指标的关联来评价其内部效度。使用Cox回归按性别分层,并对年龄、诊断年份及诊断时的住院/门诊状态进行校正,评估2年内精神分裂症住院风险。

结果

我们确定了2837例首次诊断时有GAF-F评分的精神分裂症病例(73.0%为住院患者;62.6%为男性)。GAF-F与多项功能和疾病严重程度基线指标相关,如女性、就业及较长的基线住院时间。男性中较低的GAF-F评分与较高的住院风险相关(参考GAF-F 61 - 100):GAF-F 51 - 60:风险率比(HRR)=1.24(95%置信区间[CI]=0.89 - 1.75);GAF-F 41 - 50:HRR =1.31(95% CI =0.97 - 1.77);GAF-F 31 - 40:HRR =1.36(95% CI =1.01 - 1.82);GAF-F 21 - 30:HRR =1.50(95% CI =1.09 - 2.06);GAF-F 1 - 20:HRR =2.30(95% CI =1.36 - 3.90),呈现剂量反应关系(P =0.031)。女性中未发现这种关联。

结论

在丹麦医院环境中,首次精神分裂症诊断时的GAF-F相对于其他功能指标显示出良好的内部效度。首次精神分裂症诊断时的严重损害(以GAF-F评分衡量)与男性2年住院风险较高相关,这可能表明疾病过程和治疗反应存在性别差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed52/5019159/2c5781b40313/clep-8-323Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed52/5019159/2c5781b40313/clep-8-323Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed52/5019159/2c5781b40313/clep-8-323Fig1.jpg

相似文献

1
Association between Global Assessment of Functioning scores and indicators of functioning, severity, and prognosis in first-time schizophrenia.首次发作精神分裂症患者的功能总体评估得分与功能、严重程度及预后指标之间的关联
Clin Epidemiol. 2016 Sep 2;8:323-32. doi: 10.2147/CLEP.S109036. eCollection 2016.
2
Association between global functioning at first schizophrenia diagnosis and treatment resistance.首次精神分裂症诊断时的整体功能与治疗抵抗之间的关联。
Early Interv Psychiatry. 2018 Dec;12(6):1198-1202. doi: 10.1111/eip.12522. Epub 2017 Dec 8.
3
Predictors of Nonhospitalization and Functional Response in Clozapine Treatment: A Nationwide, Population-Based Cohort Study.氯氮平治疗中未住院及功能反应的预测因素:一项基于全国人口的队列研究
J Clin Psychopharmacol. 2017 Apr;37(2):148-154. doi: 10.1097/JCP.0000000000000649.
4
A common risk variant in CACNA1C supports a sex-dependent effect on longitudinal functioning and functional recovery from episodes of schizophrenia-spectrum but not bipolar disorder.CACNA1C基因中的一个常见风险变异支持了对精神分裂症谱系发作的纵向功能和功能恢复存在性别依赖性影响,但对双相情感障碍不存在这种影响。
Eur Neuropsychopharmacol. 2015 Dec;25(12):2262-70. doi: 10.1016/j.euroneuro.2015.09.012. Epub 2015 Oct 9.
5
[Social outcome of schizophrenics in Tunisia: a transversal study of 60 patients].[突尼斯精神分裂症患者的社会结局:对60例患者的横断面研究]
Encephale. 2009 Jun;35(3):234-40. doi: 10.1016/j.encep.2008.05.001. Epub 2008 Sep 23.
6
Main determinants of Global Assessment of Functioning score in schizophrenia: a European multicenter study.精神分裂症中功能总体评定量表得分的主要决定因素:一项欧洲多中心研究
Compr Psychiatry. 2005 Nov-Dec;46(6):440-6. doi: 10.1016/j.comppsych.2005.03.006.
7
Social dysfunction in schizophrenia: an investigation of the GAF scale's sensitivity to deficits in social cognition.精神分裂症的社会功能障碍:一项关于 GAF 量表对社会认知缺陷敏感性的研究。
Schizophr Res. 2013 May;146(1-3):363-5. doi: 10.1016/j.schres.2013.01.016. Epub 2013 Feb 17.
8
The MIRECC version of the Global Assessment of Functioning scale: reliability and validity.功能总体评定量表的MIRECC版本:信度与效度
Psychiatr Serv. 2007 Apr;58(4):529-35. doi: 10.1176/ps.2007.58.4.529.
9
One-year functional outcomes of naturalistically treated patients with schizophrenia.自然治疗精神分裂症患者的一年功能结局。
Psychiatry Res. 2012 Aug 15;198(3):378-85. doi: 10.1016/j.psychres.2011.12.047. Epub 2012 Mar 14.
10
Impairment in Social Functioning differentiates youth meeting Ultra-High Risk for psychosis criteria from other mental health help-seekers: A validation of the Italian version of the Global Functioning: Social and Global Functioning: Role scales.社会功能障碍可将符合精神病超高危标准的青年与其他寻求心理健康帮助的人区分开来:意大利版全球功能:社会功能和全球功能:角色量表的验证。
Psychiatry Res. 2017 Jul;253:296-302. doi: 10.1016/j.psychres.2017.04.008. Epub 2017 Apr 6.

引用本文的文献

1
Multivariable prediction of functional outcome after first-episode psychosis: a crossover validation approach in EUFEST and PSYSCAN.首发精神病后功能结局的多变量预测:EUFEST和PSYSCAN研究中的交叉验证方法
Schizophrenia (Heidelb). 2024 Oct 7;10(1):89. doi: 10.1038/s41537-024-00505-w.
2
The relationship between visual hallucinations, functioning, and suicidality over the course of illness: a 10-year follow-up study in first-episode psychosis.疾病过程中视觉幻觉、功能及自杀倾向之间的关系:一项针对首发精神病的10年随访研究
Schizophrenia (Heidelb). 2024 Mar 2;10(1):30. doi: 10.1038/s41537-024-00450-8.
3
Costs of psychotropics for outpatients with bipolar disorder in Japan; the MUSUBI 2016 survey.

本文引用的文献

1
Relationships between global assessment of functioning and other rating scales in clinical trials for schizophrenia.精神分裂症临床试验中总体功能评估与其他评定量表之间的关系。
Psychiatry Res. 2015 Jun 30;227(2-3):265-9. doi: 10.1016/j.psychres.2015.02.024. Epub 2015 Apr 1.
2
Clinical predictors of therapeutic response to antipsychotics in schizophrenia.精神分裂症中抗精神病药物治疗反应的临床预测因素。
Dialogues Clin Neurosci. 2014 Dec;16(4):505-24. doi: 10.31887/DCNS.2014.16.4/mcarbon.
3
Equipercentile linking of scales measuring functioning and symptoms: examining the GAF, SOFAS, CGI-S, and PANSS.
日本双相情感障碍门诊患者精神药物的费用:MUSUBI 2016 调查。
Ann Med. 2023 Dec;55(1):2224047. doi: 10.1080/07853890.2023.2224047.
4
Correlates of Metabolic Syndrome in Patients with Schizophrenia: An Exploratory Study.精神分裂症患者代谢综合征的相关因素:一项探索性研究。
Indian J Clin Biochem. 2022 Apr;37(2):232-237. doi: 10.1007/s12291-020-00912-7. Epub 2020 Jul 6.
5
The prevalence of physical multimorbidity among people with non-affective psychotic disorders 10 years after first diagnosis: a matched retrospective cohort study.首发非情感性精神病性障碍 10 年后躯体多病共患的流行率:一项配对回顾性队列研究。
Soc Psychiatry Psychiatr Epidemiol. 2022 Mar;57(3):495-503. doi: 10.1007/s00127-021-02157-y. Epub 2021 Aug 6.
6
Online Survey of Clinical Practice in Patients with Schizophrenia Treated with Long-Acting Injectable Aripiprazole or Paliperidone Palmitate.长效注射用阿立哌唑或棕榈酸帕利哌酮治疗精神分裂症患者的临床实践在线调查
Neuropsychiatr Dis Treat. 2021 Jun 10;17:1881-1892. doi: 10.2147/NDT.S303292. eCollection 2021.
7
Clinical Benefit and Utility of Switching to Aripiprazole Once Monthly in Patients with Antipsychotic Polypharmacy or Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study.在常规实践中,将抗精神病药物联合使用或长效注射用抗精神病药物的精神分裂症患者换用每月一次阿立哌唑的临床益处和实用性:一项回顾性观察研究。
Clin Psychopharmacol Neurosci. 2021 May 31;19(2):233-242. doi: 10.9758/cpn.2021.19.2.233.
8
A prospective multicenter assessor-blinded randomized controlled study to compare the efficacy of short versus long protocols of electroconvulsive therapy as an augmentation strategy to clozapine in patients with ultra-resistant schizophrenia (SURECT study).一项前瞻性、多中心、评估者设盲、随机对照研究,旨在比较电抽搐治疗的短程与长程方案作为增效策略,与氯氮平联合治疗超难治性精神分裂症的疗效(SURECT 研究)。
Trials. 2021 Apr 15;22(1):284. doi: 10.1186/s13063-021-05227-3.
9
Progressive Impairment of Mismatch Negativity Is Reflective of Underlying Pathophysiological Changes in Patients With First-Episode Psychosis.失配负波的进行性损害反映了首发精神病患者潜在的病理生理变化。
Front Psychiatry. 2020 Jun 18;11:587. doi: 10.3389/fpsyt.2020.00587. eCollection 2020.
10
Specificity of executive functioning and processing speed problems in common psychopathology.常见精神病理学中执行功能和处理速度问题的特异性
Neuropsychology. 2017 May;31(4):448-466. doi: 10.1037/neu0000343. Epub 2017 Jan 16.
等百分位关联量表测量功能和症状:检验 GAF、SOFAS、CGI-S 和 PANSS。
Eur Neuropsychopharmacol. 2014 Nov;24(11):1767-72. doi: 10.1016/j.euroneuro.2014.08.009. Epub 2014 Aug 20.
4
A review on schizophrenia and relapse--a quest for user-friendly psychopharmacotherapy.关于精神分裂症与复发的综述——寻求便于使用的精神药物治疗方法
Hum Psychopharmacol. 2014 Sep;29(5):414-26. doi: 10.1002/hup.2421.
5
How successful are first episode programs? A review of the evidence for specialized assertive early intervention.首发项目的成效如何?针对专门的积极主动早期干预的证据综述。
Curr Opin Psychiatry. 2014 May;27(3):167-72. doi: 10.1097/YCO.0000000000000052.
6
Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review.精神分裂症患者复发的定义和驱动因素:系统文献回顾。
Ann Gen Psychiatry. 2013 Oct 23;12(1):32. doi: 10.1186/1744-859X-12-32.
7
Predictors of recovery in first episode psychosis: the OPUS cohort at 10 year follow-up.首发精神病患者康复的预测因素:10 年随访的 OPUS 队列研究。
Schizophr Res. 2013 Oct;150(1):163-8. doi: 10.1016/j.schres.2013.07.031. Epub 2013 Aug 8.
8
The validity of the schizophrenia diagnosis in the Danish Psychiatric Central Research Register is good.丹麦精神病学中央研究登记册中精神分裂症诊断的有效性良好。
Dan Med J. 2013 Feb;60(2):A4578.
9
Prediction of acute clinical response following a first episode of non affective psychosis: results of a cohort of 375 patients from the Spanish PAFIP study.首发非情感性精神病后急性临床反应的预测:来自西班牙 PAFIP 研究的 375 例患者队列的结果。
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jul 1;44:162-7. doi: 10.1016/j.pnpbp.2013.02.009. Epub 2013 Feb 20.
10
Gender differences in first-episode psychosis at 5-year follow-up--two different courses of disease? Results from the OPUS study at 5-year follow-up.首发精神病患者 5 年随访期的性别差异——疾病的两种不同病程?OPUS 研究 5 年随访结果。
Eur Psychiatry. 2014 Jan;29(1):44-51. doi: 10.1016/j.eurpsy.2012.11.005. Epub 2013 Feb 8.